80 related articles for article (PubMed ID: 21925502)
1. Building on the foundation of daring hypotheses: using the MKK4 metastasis suppressor to develop models of dormancy and metastatic colonization.
Knopeke MT; Ritschdorff ET; Clark R; Vander Griend DJ; Khan S; Thobe M; Shear JB; Rinker-Schaeffer CW
FEBS Lett; 2011 Oct; 585(20):3159-65. PubMed ID: 21925502
[TBL] [Abstract][Full Text] [Related]
2. Using MKK4's metastasis suppressor function to identify and dissect cancer cell-microenvironment interactions during metastatic colonization.
Krishnan V; Stadick N; Clark R; Bainer R; Veneris JT; Khan S; Drew A; Rinker-Schaeffer C
Cancer Metastasis Rev; 2012 Dec; 31(3-4):605-13. PubMed ID: 22706843
[TBL] [Abstract][Full Text] [Related]
3. FOCUS ON…metastasis suppressors.
Just W
FEBS Lett; 2011 Oct; 585(20):3147. PubMed ID: 21946311
[No Abstract] [Full Text] [Related]
4. The p38 kinases MKK4 and MKK6 suppress metastatic colonization in human ovarian carcinoma.
Hickson JA; Huo D; Vander Griend DJ; Lin A; Rinker-Schaeffer CW; Yamada SD
Cancer Res; 2006 Feb; 66(4):2264-70. PubMed ID: 16489030
[TBL] [Abstract][Full Text] [Related]
5. Mitogen-activated protein kinase kinase 4 (MKK4) acts as a metastasis suppressor gene in human ovarian carcinoma.
Yamada SD; Hickson JA; Hrobowski Y; Vander Griend DJ; Benson D; Montag A; Karrison T; Huo D; Rutgers J; Adams S; Rinker-Schaeffer CW
Cancer Res; 2002 Nov; 62(22):6717-23. PubMed ID: 12438272
[TBL] [Abstract][Full Text] [Related]
6. New paradigms for the function of JNKK1/MKK4 in controlling growth of disseminated cancer cells.
Taylor JL; Szmulewitz RZ; Lotan T; Hickson J; Griend DV; Yamada SD; Macleod K; Rinker-Schaeffer CW
Cancer Lett; 2008 Dec; 272(1):12-22. PubMed ID: 18572308
[TBL] [Abstract][Full Text] [Related]
7. Suppression of metastatic colonization by the context-dependent activation of the c-Jun NH2-terminal kinase kinases JNKK1/MKK4 and MKK7.
Vander Griend DJ; Kocherginsky M; Hickson JA; Stadler WM; Lin A; Rinker-Schaeffer CW
Cancer Res; 2005 Dec; 65(23):10984-91. PubMed ID: 16322247
[TBL] [Abstract][Full Text] [Related]
8. MKK4 suppresses metastatic colonization by multiple highly metastatic prostate cancer cell lines through a transient impairment in cell cycle progression.
Szmulewitz RZ; Clark R; Lotan T; Otto K; Taylor Veneris J; Macleod K; Rinker-Schaeffer C
Int J Cancer; 2012 Feb; 130(3):509-20. PubMed ID: 21351092
[TBL] [Abstract][Full Text] [Related]
9. Mitogen-activated protein kinase kinase 4/stress-activated protein/Erk kinase 1 (MKK4/SEK1), a prostate cancer metastasis suppressor gene encoded by human chromosome 17.
Yoshida BA; Dubauskas Z; Chekmareva MA; Christiano TR; Stadler WM; Rinker-Schaeffer CW
Cancer Res; 1999 Nov; 59(21):5483-7. PubMed ID: 10554023
[TBL] [Abstract][Full Text] [Related]
10. Human mitogen-activated protein kinase kinase 4 as a candidate tumor suppressor.
Teng DH; Perry WL; Hogan JK; Baumgard M; Bell R; Berry S; Davis T; Frank D; Frye C; Hattier T; Hu R; Jammulapati S; Janecki T; Leavitt A; Mitchell JT; Pero R; Sexton D; Schroeder M; Su PH; Swedlund B; Kyriakis JM; Avruch J; Bartel P; Wong AK; Tavtigian SV
Cancer Res; 1997 Oct; 57(19):4177-82. PubMed ID: 9331070
[TBL] [Abstract][Full Text] [Related]
11. [Tumor dormancy and identification of therapeutic targets].
Li CF; Cao S; Meng SD
Ai Zheng; 2009 May; 28(5):555-8. PubMed ID: 19624889
[TBL] [Abstract][Full Text] [Related]
12. Exploring cancer metastasis prevention strategy: interrupting adhesion of cancer cells to vascular endothelia of potential metastatic tissues by antibody-coated nanomaterial.
Xie J; Dong H; Chen H; Zhao R; Sinko PJ; Shen W; Wang J; Lu Y; Yang X; Xie F; Jia L
J Nanobiotechnology; 2015 Feb; 13():9. PubMed ID: 25643843
[TBL] [Abstract][Full Text] [Related]
13. Mitogen-activated protein kinase kinase 4 metastasis suppressor gene expression is inversely related to histological pattern in advancing human prostatic cancers.
Kim HL; Vander Griend DJ; Yang X; Benson DA; Dubauskas Z; Yoshida BA; Chekmareva MA; Ichikawa Y; Sokoloff MH; Zhan P; Karrison T; Lin A; Stadler WM; Ichikawa T; Rubin MA; Rinker-Schaeffer CW
Cancer Res; 2001 Apr; 61(7):2833-7. PubMed ID: 11306453
[TBL] [Abstract][Full Text] [Related]
14. Metastasis suppression: the evolving role of metastasis suppressor genes for regulating cancer cell growth at the secondary site.
Kauffman EC; Robinson VL; Stadler WM; Sokoloff MH; Rinker-Schaeffer CW
J Urol; 2003 Mar; 169(3):1122-33. PubMed ID: 12576866
[TBL] [Abstract][Full Text] [Related]
15. Current status in human breast cancer micrometastasis.
Alix-Panabières C; Müller V; Pantel K
Curr Opin Oncol; 2007 Nov; 19(6):558-63. PubMed ID: 17906452
[TBL] [Abstract][Full Text] [Related]
16. Functional and clinicopathological analysis of loss of MKK4 expression in endometrial cancer.
Ishikawa M; Nakayama K; Rahman MT; Rahman M; Katagiri A; Iida K; Miyazaki K
Oncology; 2010; 79(3-4):238-46. PubMed ID: 21372598
[TBL] [Abstract][Full Text] [Related]
17. Targeted deletion of MKK4 in cancer cells: a detrimental phenotype manifests as decreased experimental metastasis and suggests a counterweight to the evolution of tumor-suppressor loss.
Cunningham SC; Gallmeier E; Hucl T; Dezentje DA; Calhoun ES; Falco G; Abdelmohsen K; Gorospe M; Kern SE
Cancer Res; 2006 Jun; 66(11):5560-4. PubMed ID: 16740690
[TBL] [Abstract][Full Text] [Related]
18. Role of mitogen-activated protein kinase kinase 4 in cancer.
Whitmarsh AJ; Davis RJ
Oncogene; 2007 May; 26(22):3172-84. PubMed ID: 17496914
[TBL] [Abstract][Full Text] [Related]
19. Using metastasis suppressor proteins to dissect interactions among cancer cells and their microenvironment.
Taylor J; Hickson J; Lotan T; Yamada DS; Rinker-Schaeffer C
Cancer Metastasis Rev; 2008 Mar; 27(1):67-73. PubMed ID: 18049862
[TBL] [Abstract][Full Text] [Related]
20. Drug development against metastasis-related genes and their pathways: a rationale for cancer therapy.
Iiizumi M; Liu W; Pai SK; Furuta E; Watabe K
Biochim Biophys Acta; 2008 Dec; 1786(2):87-104. PubMed ID: 18692117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
